CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: flavin
Accession: CHEBI:30527
browse the term
Definition: A derivative of the dimethylisoalloxazine (7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione) skeleton, with a substituent on the 10 position.
Synonyms: exact_synonym: flavins
related_synonym: Formula=C12H9N4O2R; SMILES=Cc1cc2nc3c(nc(=O)[nH]c3=O)n([*])c2cc1C
alt_id: CHEBI:24042; CHEBI:5073
xref: KEGG:C00176
cyclic_relationship: is_conjugate_acid_of CHEBI:60531
G
Ndufa9
NADH:ubiquinone oxidoreductase subunit A9
multiple interactions
ISO
Flavin-Adenine Dinucleotide binds to and results in increased activity of NDUFA9 protein
CTD
PMID:25526675
NCBI chr 6:126,798,826...126,826,107
Ensembl chr 6:126,798,684...126,826,099
G
Rfk
riboflavin kinase
increases abundance
ISO
RFK protein results in increased abundance of Flavin-Adenine Dinucleotide
CTD
PMID:21308351
NCBI chr19:17,371,407...17,378,713
Ensembl chr19:17,371,407...17,378,713
G
Slc52a3
solute carrier protein family 52, member 3
multiple interactions
ISO
Flavin-Adenine Dinucleotide inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]
CTD
PMID:19122205
NCBI chr 2:151,838,431...151,851,178
Ensembl chr 2:151,838,431...151,851,178
G
Idh2
isocitrate dehydrogenase 2 (NADP+), mitochondrial
multiple interactions increases abundance
EXP
Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Flavin Mononucleotide]
CTD
PMID:27469509
NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
G
Rfk
riboflavin kinase
increases abundance
ISO
RFK protein results in increased abundance of Flavin Mononucleotide
CTD
PMID:21308351
NCBI chr19:17,371,407...17,378,713
Ensembl chr19:17,371,407...17,378,713
G
Slc52a3
solute carrier protein family 52, member 3
multiple interactions
ISO
Flavin Mononucleotide inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]
CTD
PMID:19122205
NCBI chr 2:151,838,431...151,851,178
Ensembl chr 2:151,838,431...151,851,178
G
Slc52a3
solute carrier protein family 52, member 3
multiple interactions
ISO
lumiflavin inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]
CTD
PMID:19122205
NCBI chr 2:151,838,431...151,851,178
Ensembl chr 2:151,838,431...151,851,178
G
Akt1
thymoma viral proto-oncogene 1
increases phosphorylation
EXP
Riboflavin analog results in increased phosphorylation of AKT1 protein; Riboflavin results in increased phosphorylation of AKT1 protein
CTD
PMID:20688149
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Aspm
abnormal spindle microtubule assembly
affects expression
ISO
Riboflavin affects the expression of ASPM
CTD
PMID:20848206
NCBI chr 1:139,381,450...139,421,826
Ensembl chr 1:139,382,510...139,421,829
G
Bax
BCL2-associated X protein
increases expression
ISO
Riboflavin results in increased expression of BAX protein
CTD
PMID:12654180
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
decreases expression
ISO
Riboflavin results in decreased expression of BCL2 protein
CTD
PMID:12654180
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Birc5
baculoviral IAP repeat-containing 5
affects expression
ISO
Riboflavin affects the expression of BIRC5
CTD
PMID:20848206
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
G
Casp3
caspase 3
increases activity
EXP
Riboflavin analog results in increased activity of CASP3 protein
CTD
PMID:20688149
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp8
caspase 8
increases activity
EXP
Riboflavin analog results in increased activity of CASP8 protein
CTD
PMID:20688149
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Casp9
caspase 9
increases activity
EXP
Riboflavin analog results in increased activity of CASP9 protein
CTD
PMID:20688149
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cat
catalase
multiple interactions
ISO
Riboflavin inhibits the reaction [Lipopolysaccharides results in decreased expression of CAT protein]
CTD
PMID:26360969
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Ccnb1
cyclin B1
affects expression
ISO
Riboflavin affects the expression of CCNB1
CTD
PMID:20848206
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
ISO
Riboflavin deficiency results in increased expression of CEBPB mRNA; Riboflavin deficiency results in increased expression of CEBPB protein
CTD
PMID:16856317
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
G
Crp
C-reactive protein, pentraxin-related
multiple interactions
ISO
[Folic Acid co-treated with Riboflavin co-treated with Vitamin B 6 co-treated with Vitamin B 12] results in decreased expression of CRP protein; [Vitamin E co-treated with Ascorbic Acid co-treated with Folic Acid co-treated with Riboflavin co-treated with Vitamin B 6 co-treated with Vitamin B 12] results in decreased expression of CRP protein
CTD
PMID:16517955
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Ctnnb1
catenin beta 1
increases expression
EXP
Riboflavin analog results in increased expression of CTNNB1 protein
CTD
PMID:20688149
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
G
Cxcl15
C-X-C motif chemokine ligand 15
multiple interactions
ISO
[Ubiquinone co-treated with Niacin co-treated with Riboflavin] promotes the reaction [Tamoxifen results in decreased expression of CXCL8 protein]
CTD
PMID:17516992
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Ddit3
DNA-damage inducible transcript 3
affects expression
ISO
Riboflavin affects the expression of DDIT3
CTD
PMID:16109485
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
G
Gpx1
glutathione peroxidase 1
multiple interactions
ISO
Riboflavin inhibits the reaction [Lipopolysaccharides results in decreased activity of GPX1 protein]
CTD
PMID:26360969
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Gsk3b
glycogen synthase kinase 3 beta
increases phosphorylation
EXP
Riboflavin analog results in increased phosphorylation of GSK3B protein; Riboflavin results in increased phosphorylation of GSK3B protein
CTD
PMID:20688149
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
G
Gsr
glutathione reductase
affects expression multiple interactions
ISO
Riboflavin affects the expression of GSR Riboflavin inhibits the reaction [Lipopolysaccharides results in decreased activity of GSR protein]
CTD
PMID:16109485 PMID:26360969
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Ubiquinone co-treated with Niacin co-treated with Riboflavin] promotes the reaction [Tamoxifen results in decreased expression of IL1B protein]
CTD
PMID:17516992
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il6
interleukin 6
multiple interactions
ISO
[Ubiquinone co-treated with Niacin co-treated with Riboflavin] promotes the reaction [Tamoxifen results in decreased expression of IL6 protein]
CTD
PMID:17516992
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Iyd
iodotyrosine deiodinase
multiple interactions
ISO
Riboflavin inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]
CTD
PMID:33352258
NCBI chr10:3,490,274...3,504,880
Ensembl chr10:3,490,240...3,504,877
G
Kif23
kinesin family member 23
affects expression
ISO
Riboflavin affects the expression of KIF23
CTD
PMID:20848206
NCBI chr 9:61,824,559...61,854,078
Ensembl chr 9:61,823,187...61,854,056
G
Mmp9
matrix metallopeptidase 9
increases activity
EXP
Riboflavin analog results in increased activity of MMP9 protein; Riboflavin results in increased activity of MMP9 protein
CTD
PMID:20688149
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mpo
myeloperoxidase
multiple interactions
ISO
Riboflavin inhibits the reaction [Lipopolysaccharides results in increased activity of MPO protein]
CTD
PMID:26360969
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Mthfr
methylenetetrahydrofolate reductase
affects response to substance
ISO
MTHFR gene polymorphism affects the susceptibility to Riboflavin
CTD
PMID:17303386
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
G
Myc
myelocytomatosis oncogene
increases expression
ISO
Riboflavin results in increased expression of MYC protein
CTD
PMID:12654180
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Nos2
nitric oxide synthase 2, inducible
multiple interactions
EXP ISO
Lipopolysaccharides inhibits the reaction [Riboflavin results in increased expression of NOS2] Riboflavin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]
CTD
PMID:21356098 PMID:26360969
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Parp1
poly (ADP-ribose) polymerase family, member 1
multiple interactions increases cleavage
ISO EXP
[Niacin co-treated with Ubiquinone co-treated with Riboflavin] results in increased expression of PARP1 protein Riboflavin analog results in increased cleavage of PARP1 protein
CTD
PMID:18377693 PMID:20688149
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Plagl1
pleiomorphic adenoma gene-like 1
affects expression
ISO
Riboflavin affects the expression of PLAGL1
CTD
PMID:16109485
NCBI chr10:12,966,576...13,007,438
Ensembl chr10:12,936,248...13,007,438
G
Ppargc1a
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha
increases expression
ISO
Riboflavin results in increased expression of PPARGC1A mRNA
CTD
PMID:23056435
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
G
Runx2
runt related transcription factor 2
increases expression
EXP
Riboflavin analog results in increased expression of RUNX2 protein
CTD
PMID:20688149
NCBI chr17:44,806,873...45,125,518
Ensembl chr17:44,806,874...45,125,684
G
Slc52a3
solute carrier protein family 52, member 3
multiple interactions increases transport
ISO
Acids promotes the reaction [SLC52A3 protein results in increased transport of Riboflavin]; Amiloride inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]; Flavin Mononucleotide inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]; Flavin-Adenine Dinucleotide inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]; lumiflavin inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]
CTD
PMID:19122205
NCBI chr 2:151,838,431...151,851,178
Ensembl chr 2:151,838,431...151,851,178
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
[Ubiquinone co-treated with Niacin co-treated with Riboflavin] promotes the reaction [Tamoxifen results in decreased expression of TNF protein] Lipopolysaccharides inhibits the reaction [Riboflavin results in increased expression of TNF]
CTD
PMID:17516992 PMID:21356098
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfsf11
tumor necrosis factor (ligand) superfamily, member 11
affects expression
EXP
Riboflavin analog affects the expression of TNFSF11 protein
CTD
PMID:20688149
NCBI chr14:78,514,886...78,545,483
Ensembl chr14:78,514,885...78,545,483
G
Trp53
transformation related protein 53
increases expression
ISO
Riboflavin results in increased expression of TP53 protein
CTD
PMID:12654180
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
22178
chemical entity
22208
atom
22170
nonmetal atom
22055
nitrogen atom
20030
nitrogen molecular entity
20004
organonitrogen compound
19809
organonitrogen heterocyclic compound
19099
benzopteridine
39
flavin
38
1-(a-ribofuranosyl)-lumichrome
0
1-methyl-11-hydroxylumichrome
0
10H-phenanthro[9,10-g]pteridine-11,13-dione
0
6,7-Dimethyl-9-(2-acetoxyethyl)isoalloxazine
0
7,10-dimethyl-2,4-dioxo-8-benzo[g]pteridinecarboxaldehyde
0
7,8-dimethyl-10-[(2R,3R,4S)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione
0
7,8-dimethylisoalloxazine-10-carbaldehyde
0
Lampteroflavin
0
Ochangoside
0
Riboflavin butyrate
0
Riboflavine 2',3',4',5'-tetrabutanoate
0
Riboflavol
0
dihydroriboflavins +
0
flavin adenine dinucleotide +
3
flavin mononucleotide +
3
flavoprotein +
0
lumiflavin
1
riboflavin +
35
Path 2
CHEBI ontology
22178
subatomic particle
22170
composite particle
22170
hadron
22201
baryon
22170
nucleon
22170
atomic nucleus
22170
atom
22170
main group element atom
22104
p-block element atom
22104
carbon group element atom
21904
carbon atom
21859
organic molecular entity
21830
organic molecule
21647
organic cyclic compound
21252
organic heterocyclic compound
20352
organic heteropolycyclic compound
19645
organic heterotricyclic compound
16298
benzopteridine
39
benzo[g]pteridine-2,4-dione
39
isoalloxazine
38
7,8-dimethylisoalloxazine
38
flavin
38
1-(a-ribofuranosyl)-lumichrome
0
1-methyl-11-hydroxylumichrome
0
10H-phenanthro[9,10-g]pteridine-11,13-dione
0
6,7-Dimethyl-9-(2-acetoxyethyl)isoalloxazine
0
7,10-dimethyl-2,4-dioxo-8-benzo[g]pteridinecarboxaldehyde
0
7,8-dimethyl-10-[(2R,3R,4S)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione
0
7,8-dimethylisoalloxazine-10-carbaldehyde
0
Lampteroflavin
0
Ochangoside
0
Riboflavin butyrate
0
Riboflavine 2',3',4',5'-tetrabutanoate
0
Riboflavol
0
dihydroriboflavins +
0
flavin adenine dinucleotide +
3
flavin mononucleotide +
3
flavoprotein +
0
lumiflavin
1
riboflavin +
35